Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.

Abstract

PURPOSE Biomarkers for the early detection of pancreatic cancer are urgently needed. The primary objective of this study was to evaluate whether increased levels of serum CA19-9, CA125, CEACAM1, and REG3A are present before clinical presentation of pancreatic cancer and to assess the performance of combined markers for early detection and prognosis… (More)
DOI: 10.1158/1078-0432.CCR-14-0365

Topics

5 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics